Table 2 shows the baseline characteristics of the study population. Figure 2 compares the distribution of the different genotype-predicted phenotypes of CYP2C19 and CYP2D6. The proportion of UMs in CYP2C19 was significantly larger for the LL-patients (8.5%) compared to the CAD-patients (4.0%). This evidence concerns the gene CYP2C19 and coronary artery disorder.